Skip to content

Public FDA record

Z-0788-2016: Endobon-Xenograft Granules, Zimmer Biomet, Synthetic Bone Grafting Material, used in dental and/or surgic

Recall record Z-0788-2016 for Biomet France SARL. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0788-2016
Company in FDA record
Biomet France SARL
FDA classification date
Feb 9, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Cytotoxicity tests were not passed at 36 months. Use of Endobon-Xenograft Granules past 18 months of its specified shelf life may result in patient illness/injury.

Source facts

Action
Zimmer BIOMET France SARL has initiated a voluntary recall via certified mail on January 2, /2016 for the Endobon Xenograft Granules, based on limited (in vitro/bench) results which indicated cytotoxicity tests were not passed at 36 months (real-time) aging. Use of the Endobon Xenograft Granules may result in patient may experiencing soft tissue irritation, up to and including infection. Customers area asked to do the following: 1. Please review this notice. 2. Identify, remove from service and segregate all affected Endobon ROX* product in your inventory. 3. Complete the attached Business Reply Form (Attachment 1) and: a. Fax it to 877-650-0368 or email it to Biomet5351@stericycle.com. 4. If you have product to return, contact BIOMET 3i at the number on the Business Reply Form for an RMA number and return shipping label. a. Return a copy of the Business Reply Form along with any affected product to the address on the Business Reply Form. Replacement product will immediately ship based upon availability. For assistance or other questions that customers may have relative to this notice, please contact BIOMET 3i at 1-800-443-8166 or 1-561-776-6700. Team members are available to assist you 8:00am to 6:00pm (Eastern), Monday through Friday.
Initiated
2016-01-21
Root cause
Under Investigation by firm
Terminated
2017-05-31
Distribution
Worldwide Distribution - US including AL, AK, AR, AK, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MN, MI, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV and Internationally to Canada, Japan, Europe.
Recall number
Z-0788-2016
Recall status
Terminated
CDRH record ID
143158
FDA classified
2016-02-09
Recall event number
73141

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗